NEWS DETAIL

Percubaan COLOSOTO: Sotorasib + Panitumumab + 5-FU sebagai Rawatan Barisan Pertama untuk Kanser Kolorektal Mutan KRAS G12C – Oncodaily

Percubaan COLOSOTO: Sotorasib + Panitumumab + 5-FU sebagai Rawatan Barisan Pertama untuk Kanser Kolorektal Mutan KRAS G12C (Oncodaily)

Maklumat Perubatan July 2, 2026

Kandungan penuh artikel

COLOSOTO Trial: Sotorasib + Panitumumab + 5-FU as 1L Therapy in KRAS G12C Mutated Colorectal Cancer / cancer, cancer care, Cancer research, cancer treatment, , cancer, cancer care, Cancer research, cancer treatment, chemotherapy, colorectal cancer, COLOSOTO, KRAS G12C, OncoDaily, Oncology, Sotorasib, Target therapy

Produk Berkaitan Artikel Ini

Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.

Soalan Lazim

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Sotorasib – Beli dalam talian SOTOLDX Sotorasib 120mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.